Search - tctmd.com

Displaying 181 - 200 of 372

Sort: Relevancy | Date

Presentation TCT 2019

Epicardial (Ipsilateral and Contralateral) Collateral Perforation: Prevention and Management

Presenter: Alexandre Avran

September 28, 2019

Presentation TCT 2019

Septal Collateral Perforations: Prevention and Management

Presenter: Roberto Garbo

September 28, 2019

Presentation TCT 2019

Antegrade Distal Wire Perforations: Prevention and Management

Presenter: Kathleen Kearney

September 28, 2019

Presentation TCT 2019

Antegrade Wire or Device Exit at the CTO Site: Prevention and Management

Presenter: Nicholas Lembo

September 28, 2019

Presentation TCT 2019

Complication Recognition Before It’s Obvious: Anticipating Disaster

Presenter: Anthony Spaedy

September 28, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

Presenter: Hitinder Gurm

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

Stroke Prevention Strategies...and Endovascular Techniques When Prevention Fails

Presenter: Christopher Stapleton

September 28, 2019

Presentation TCT 2019

How Could Advances in Digital Health Help in the Prevention of CV Diseases?: E-Prevention

Presenter: Mohammad El Tahlawi

September 28, 2019

Presentation TCT 2019

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Presenter: Davide Capodanno

September 28, 2019

Presentation TCT 2019

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Presenter: Bon-Kwon Koo

September 27, 2019

Presentation TCT 2019

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: Ryan Madder

September 27, 2019

Presentation TCT 2019

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: James Min

September 27, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Presentation TCT 2019

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Presenter: Seung-Jung Park

September 27, 2019

Presentation TCT 2019

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Presenter: David Erlinge

September 27, 2019

Presentation TCT 2019

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

Presenter: Ron Waksman

September 27, 2019

Advertisement

Epicardial (Ipsilateral and Contralateral) Collateral Perforation: Prevention and Management

Septal Collateral Perforations: Prevention and Management

Antegrade Distal Wire Perforations: Prevention and Management

Antegrade Wire or Device Exit at the CTO Site: Prevention and Management

Complication Recognition Before It’s Obvious: Anticipating Disaster

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Stroke Prevention Strategies...and Endovascular Techniques When Prevention Fails

How Could Advances in Digital Health Help in the Prevention of CV Diseases?: E-Prevention

Aspirin Use for Primary and Secondary Prevention: Critical Appraisal of What We Know and What We Don't

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Treatment of Vulnerable Patients and Plaques: PREVENT Rationale and Update

Detection of Vulnerable Patients by NIRS (PROSPECT II) and Treatment (PROSPECT ABSORB) Rationale and Update

Updated Results and Implications of the Lipid-Rich Plaque Study of NIR Spectroscopy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content